CiRA Reporter

CiRA Reporter

Home › News & Events › CiRA Reporter › Funding Basic and Clinical Research with Invaluable Donor Support

Support

October 30, 2023

Funding Basic and Clinical Research with Invaluable Donor Support

The iPS Cell Research Fund has established a research support system using your generous donations to support CiRA researchers in various ways. Here, we will provide an overview of the funding support system and introduce two researchers whose cutting-edge work benefits from your wonderful contributions.

iPS Cell Research Fund Research Support System
Program Outline
Outline/Outline
  • Challenging Research Incentive Grant

  • Challenging Research Incentive Grant

Seed funding to support innovative and emerging research projects before application for competitive external research funding
  • Core Research Support Grant

  • Core Research Support Grant

Bridge funding to support ongoing outstanding research projects between
grant cycles
  • Young Investigator Development Fellowship

  • Young Investigator Development Fellowship

Fellowships to recruit and develop the next generation of research leaders
  • Research Internship Support Grant

  • Research Internship Support Grant

Funding to partially support short-term research stays by external students for training at CiRA
  • International Research Exchange Support Grant

  • International Research Exchange Support Grant

Funding to host active researchers from outside Japan for short-term research sabbaticals
  • Specially Promoted Research Grant

  • Specially Promoted Research Grant

Funding to support research with great potential for translation into clinical trials and other regenerative medicine or disease-oriented research
  • Laboratory Startup Support Grant

  • Laboratory Startup Support Grant

Initial funding to support newly appointed principal investigators to start new laboratories at CiRA
Researchers supported by the iPS Cell Research Fund Research
Support System
Shunsuke F. Shimobayashi, Associate Professor
(Laboratory Startup Support Grant)

Dr. Shimobayashi initiated his laboratory at CiRA in May 2022 after his postdoctoral training at Princeton University in the United States. To set up his laboratory from scratch, he has been using these startup funds to purchase essential research equipment to jumpstart his work.

"I would like to develop further the research I started at Princeton with new directions in Japan. My team and I will do our best to translate our basic research on cellular reprogramming for clinical applications and bring them to patients as soon as possible. Thank you for your wonderful support."


Akinori Yuzuriha, Researcher
(Young Investigator Development Fellowship)

Dr. Yuzuriha is a researcher working on red blood cells in the Koji Eto Laboratory (Department of Clinical Application) at CiRA. By studying the process of nucleus removal from erythroblasts during differentiation, he aims to establish new technologies to produce safe red blood cells for transfusion from iPS cells and other sources.

"We are using your generous support to pioneer new options for regenerative medicine. We will continue our efforts to return the goodwill you have provided us back to patients."

Shunsuke F. Shimobayashi,
Associate Professor

(Laboratory Startup Support Grant)

Dr. Shimobayashi initiated his laboratory at CiRA in May 2022 after his postdoctoral training at Princeton University in the United States. To set up his laboratory from scratch, he has been using these startup funds to purchase essential research equipment to jumpstart his work.

"I would like to develop further the research I started at Princeton with new directions in Japan. My team and I will do our best to translate our basic research on cellular reprogramming for clinical applications and bring them to patients as soon as possible. Thank you for your wonderful support."


Akinori Yuzuriha, Researcher
(Young Investigator Development Fellowship)

Dr. Yuzuriha is a researcher working on red blood cells in the Koji Eto Laboratory (Department of Clinical Application) at CiRA. By studying the process of nucleus removal from erythroblasts during differentiation, he aims to establish new technologies to produce safe red blood cells for transfusion from iPS cells and other sources.

"We are using your generous support to pioneer new options for regenerative medicine. We will continue our efforts to return the goodwill you have provided us back to patients."

go top